PUBLICATION
Humanizing the zebrafish liver shifts drug metabolic profiles and improves pharmacokinetics of CYP3A4 substrates
- Authors
- Poon, K.L., Wang, X., Ng, A.S., Goh, W.H., McGinnis, C., Fowler, S., Carney, T.J., Wang, H., Ingham, P.W.
- ID
- ZDB-PUB-160804-8
- Date
- 2017
- Source
- Archives of toxicology 91(3): 1187-1197 (Journal)
- Registered Authors
- Carney, Tom, Ingham, Philip, Poon, Kar Lai, Wang, Xingang
- Keywords
- CYP3A4, Humanized, Liver, Microsomes, Midazolam, Toxicity, Zebrafish
- MeSH Terms
-
- Animals
- Animals, Genetically Modified
- Chromatography, High Pressure Liquid
- Cytochrome P-450 CYP3A/genetics*
- Cytochrome P-450 CYP3A/metabolism
- Humans
- Hydrophobic and Hydrophilic Interactions
- Inactivation, Metabolic
- Liver/drug effects*
- Liver/metabolism
- Mass Spectrometry
- Pharmaceutical Preparations/chemistry
- Pharmacokinetics*
- Solubility
- Toxicity Tests/methods*
- Zebrafish/genetics*
- PubMed
- 27485346 Full text @ Arch. Toxicol.
- CTD
- 27485346
Citation
Poon, K.L., Wang, X., Ng, A.S., Goh, W.H., McGinnis, C., Fowler, S., Carney, T.J., Wang, H., Ingham, P.W. (2017) Humanizing the zebrafish liver shifts drug metabolic profiles and improves pharmacokinetics of CYP3A4 substrates. Archives of toxicology. 91(3):1187-1197.
Abstract
Understanding and predicting whether new drug candidates will be safe in the clinic is a critical hurdle in pharmaceutical development, that relies in part on absorption, distribution, metabolism, excretion and toxicology studies in vivo. Zebrafish is a relatively new model system for drug metabolism and toxicity studies, offering whole organism screening coupled with small size and potential for high-throughput screening. Through toxicity and absorption analyses of a number of drugs, we find that zebrafish is generally predictive of drug toxicity, although assay outcomes are influenced by drug lipophilicity which alters drug uptake. In addition, liver microsome assays reveal specific differences in metabolism of compounds between human and zebrafish livers, likely resulting from the divergence of the cytochrome P450 superfamily between species. To reflect human metabolism more accurately, we generated a transgenic "humanized" zebrafish line that expresses the major human phase I detoxifying enzyme, CYP3A4, in the liver. Here, we show that this humanized line shows an elevated metabolism of CYP3A4-specific substrates compared to wild-type zebrafish. The generation of this first described humanized zebrafish liver suggests such approaches can enhance the accuracy of the zebrafish model for toxicity prediction.
Genes / Markers
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Orthology
Engineered Foreign Genes
Mapping